| 0 |
BENIGN MESOTHELIOMA |
2 |
0.2857 |
| 1 |
EXPOSURE TO CHEMICAL POLLUTION |
305 |
0.1808 |
| 2 |
MESOTHELIOMA MALIGNANT |
57 |
0.1545 |
| 3 |
MESOTHELIOMA |
176 |
0.1355 |
| 4 |
MESOBLASTIC NEPHROMA |
1 |
0.1250 |
| 5 |
PERICARDIAL MESOTHELIOMA MALIGNANT |
1 |
0.1111 |
| 6 |
EPITHELIOID MESOTHELIOMA |
38 |
0.1083 |
| 7 |
PLEURAL MESOTHELIOMA |
13 |
0.0956 |
| 8 |
SARCOMATOID MESOTHELIOMA |
7 |
0.0933 |
| 9 |
PERITONEAL MESOTHELIOMA MALIGNANT |
18 |
0.0933 |
| 10 |
PLEURAL MESOTHELIOMA MALIGNANT |
28 |
0.0906 |
| 11 |
PINEAL PARENCHYMAL NEOPLASM MALIGNANT |
1 |
0.0588 |
| 12 |
BIPHASIC MESOTHELIOMA |
2 |
0.0465 |
| 13 |
OCCUPATIONAL EXPOSURE TO TOXIC AGENT |
10 |
0.0352 |
| 14 |
ASBESTOSIS |
7 |
0.0247 |
| 15 |
LIFE EXPECTANCY SHORTENED |
12 |
0.0212 |
| 16 |
BULLOUS IMPETIGO |
1 |
0.0167 |
| 17 |
SEPARATION ANXIETY DISORDER |
1 |
0.0084 |
| 18 |
DEFORMITY |
78 |
0.0083 |
| 19 |
DISABILITY |
130 |
0.0066 |
| 20 |
QUALITY OF LIFE DECREASED |
86 |
0.0064 |
| 21 |
B-CELL SMALL LYMPHOCYTIC LYMPHOMA |
1 |
0.0043 |
| 22 |
PLEURAL INFECTION |
1 |
0.0043 |
| 23 |
BIOPSY SKIN ABNORMAL |
1 |
0.0042 |
| 24 |
PHYSICAL DISABILITY |
18 |
0.0041 |
| 25 |
FOREIGN BODY REACTION |
1 |
0.0041 |
| 26 |
INJURY |
198 |
0.0028 |
| 27 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
13 |
0.0020 |
| 28 |
GRIEF REACTION |
1 |
0.0019 |
| 29 |
DERMATOSIS |
1 |
0.0016 |
| 30 |
BRAIN CANCER METASTATIC |
1 |
0.0014 |
| 31 |
GINGIVAL ABSCESS |
1 |
0.0013 |
| 32 |
IMMUNE-MEDIATED ADRENAL INSUFFICIENCY |
1 |
0.0013 |
| 33 |
METABOLIC ALKALOSIS |
2 |
0.0012 |
| 34 |
ALTERED VISUAL DEPTH PERCEPTION |
1 |
0.0012 |
| 35 |
CIRCADIAN RHYTHM SLEEP DISORDER |
1 |
0.0012 |
| 36 |
BLOOD ALBUMIN INCREASED |
1 |
0.0011 |
| 37 |
DEVICE RELATED THROMBOSIS |
1 |
0.0010 |
| 38 |
ACQUIRED HAEMOPHILIA |
1 |
0.0010 |
| 39 |
FULL BLOOD COUNT INCREASED |
1 |
0.0008 |
| 40 |
ANXIETY |
222 |
0.0008 |
| 41 |
EMOTIONAL DISTRESS |
92 |
0.0008 |
| 42 |
FANCONI SYNDROME |
1 |
0.0007 |
| 43 |
AUDITORY DISORDER |
1 |
0.0007 |
| 44 |
BLADDER TRANSITIONAL CELL CARCINOMA |
1 |
0.0007 |
| 45 |
LUNG ADENOCARCINOMA |
2 |
0.0007 |
| 46 |
MOUTH INJURY |
1 |
0.0007 |
| 47 |
INFECTIOUS PLEURAL EFFUSION |
1 |
0.0007 |
| 48 |
RUBBER SENSITIVITY |
1 |
0.0007 |
| 49 |
SCLERITIS |
1 |
0.0006 |
| 50 |
SKIN NECROSIS |
3 |
0.0006 |
| 51 |
PAPILLARY THYROID CANCER |
1 |
0.0006 |
| 52 |
IMMUNE-MEDIATED LUNG DISEASE |
1 |
0.0005 |
| 53 |
LUNG NEOPLASM MALIGNANT |
22 |
0.0005 |
| 54 |
TRAUMATIC LUNG INJURY |
1 |
0.0005 |
| 55 |
APLASIA |
1 |
0.0005 |
| 56 |
POLYCYTHAEMIA |
1 |
0.0005 |
| 57 |
ATRIAL THROMBOSIS |
1 |
0.0005 |
| 58 |
SOCIAL PROBLEM |
2 |
0.0005 |
| 59 |
REACTION TO DRUG EXCIPIENTS |
1 |
0.0005 |
| 60 |
SQUAMOUS CELL CARCINOMA |
4 |
0.0004 |
| 61 |
VARICELLA |
1 |
0.0004 |
| 62 |
PAIN |
257 |
0.0004 |
| 63 |
HYPERNATRAEMIA |
2 |
0.0004 |
| 64 |
METASTASES TO PERITONEUM |
1 |
0.0004 |
| 65 |
PHYSICAL DECONDITIONING |
1 |
0.0004 |
| 66 |
ACTINIC KERATOSIS |
1 |
0.0004 |
| 67 |
POSTMENOPAUSAL HAEMORRHAGE |
1 |
0.0004 |
| 68 |
RASH MORBILLIFORM |
1 |
0.0004 |
| 69 |
RESPIRATORY SYMPTOM |
1 |
0.0004 |
| 70 |
MIXED LIVER INJURY |
1 |
0.0003 |
| 71 |
MULTIPLE INJURIES |
2 |
0.0003 |
| 72 |
ABNORMAL LOSS OF WEIGHT |
2 |
0.0003 |
| 73 |
PULMONARY TOXICITY |
2 |
0.0003 |
| 74 |
IMMUNE-MEDIATED ENTEROCOLITIS |
1 |
0.0003 |
| 75 |
DISCOMFORT |
16 |
0.0003 |
| 76 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
1 |
0.0003 |
| 77 |
MUSCLE RUPTURE |
1 |
0.0003 |
| 78 |
HYPERURICAEMIA |
1 |
0.0002 |
| 79 |
HALLUCINATIONS, MIXED |
1 |
0.0002 |
| 80 |
CARDIAC FAILURE CHRONIC |
1 |
0.0002 |
| 81 |
ILLNESS |
23 |
0.0002 |
| 82 |
PNEUMONIA BACTERIAL |
2 |
0.0002 |
| 83 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
10 |
0.0002 |
| 84 |
BREATH SOUNDS ABNORMAL |
1 |
0.0002 |
| 85 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 86 |
GASTROINTESTINAL SOUNDS ABNORMAL |
1 |
0.0002 |
| 87 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
1 |
0.0002 |
| 88 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 89 |
ANHEDONIA |
5 |
0.0002 |
| 90 |
ANAL FISTULA |
1 |
0.0002 |
| 91 |
ANAL ABSCESS |
1 |
0.0002 |
| 92 |
ASPIRATION |
2 |
0.0002 |
| 93 |
PLEURAL EFFUSION |
11 |
0.0002 |
| 94 |
HYPERVENTILATION |
1 |
0.0002 |
| 95 |
DECREASED INTEREST |
1 |
0.0002 |
| 96 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
1 |
0.0002 |
| 97 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 98 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 99 |
IMPAIRED WORK ABILITY |
3 |
0.0001 |
| 100 |
IMPAIRED QUALITY OF LIFE |
2 |
0.0001 |
| 101 |
LETHARGY |
8 |
0.0001 |
| 102 |
MENTAL DISORDER |
6 |
0.0001 |
| 103 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 104 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 105 |
POLYURIA |
1 |
0.0001 |
| 106 |
PSYCHOLOGICAL TRAUMA |
1 |
0.0001 |
| 107 |
MULTI-ORGAN FAILURE |
2 |
0.0001 |
| 108 |
CARDIAC MURMUR |
1 |
0.0001 |
| 109 |
SPINAL OSTEOARTHRITIS |
1 |
0.0001 |
| 110 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 111 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 112 |
POST PROCEDURAL COMPLICATION |
2 |
0.0001 |
| 113 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 114 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 115 |
PULMONARY HYPERTENSION |
2 |
0.0001 |
| 116 |
DYSPHAGIA |
9 |
0.0001 |
| 117 |
SUDDEN DEATH |
1 |
0.0001 |
| 118 |
RETCHING |
2 |
0.0001 |
| 119 |
MALNUTRITION |
1 |
0.0001 |
| 120 |
SKIN INFECTION |
1 |
0.0001 |
| 121 |
LUNG DISORDER |
4 |
0.0001 |
| 122 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 123 |
FEAR |
2 |
0.0001 |
| 124 |
PNEUMONITIS |
2 |
0.0001 |
| 125 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 126 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 127 |
COLON CANCER |
1 |
0.0001 |
| 128 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 129 |
LUNG INFECTION |
1 |
0.0001 |
| 130 |
INTERSTITIAL LUNG DISEASE |
3 |
0.0001 |
| 131 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 132 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 133 |
NERVOUSNESS |
3 |
0.0001 |
| 134 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 135 |
DECREASED APPETITE |
13 |
0.0001 |
| 136 |
ELECTROCARDIOGRAM QT PROLONGED |
2 |
0.0001 |
| 137 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 138 |
FOOT FRACTURE |
1 |
0.0001 |
| 139 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 140 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 141 |
GENERAL PHYSICAL HEALTH DETERIORATION |
6 |
0.0001 |
| 142 |
WEIGHT DECREASED |
14 |
0.0001 |
| 143 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 144 |
SOMNOLENCE |
10 |
0.0000 |
| 145 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 146 |
TASTE DISORDER |
1 |
0.0000 |
| 147 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 148 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 149 |
POLLAKIURIA |
2 |
0.0000 |
| 150 |
TOOTH DISORDER |
1 |
0.0000 |
| 151 |
SHOCK |
1 |
0.0000 |
| 152 |
HYPOKALAEMIA |
2 |
0.0000 |
| 153 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 154 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 155 |
HYPOPHAGIA |
1 |
0.0000 |
| 156 |
HEPATITIS |
1 |
0.0000 |
| 157 |
PERIPHERAL SWELLING |
6 |
0.0000 |
| 158 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0000 |
| 159 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 160 |
EAR INFECTION |
1 |
0.0000 |
| 161 |
THROMBOSIS |
3 |
0.0000 |
| 162 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 163 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 164 |
HAEMOPTYSIS |
1 |
0.0000 |
| 165 |
PANCYTOPENIA |
2 |
0.0000 |
| 166 |
BLISTER |
2 |
0.0000 |
| 167 |
DEPRESSION |
8 |
0.0000 |
| 168 |
OESOPHAGEAL CARCINOMA |
1 |
0.0000 |
| 169 |
RENAL INJURY |
1 |
0.0000 |
| 170 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 171 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 172 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 173 |
NIGHT SWEATS |
1 |
0.0000 |
| 174 |
DYSPNOEA |
17 |
0.0000 |
| 175 |
GAIT INABILITY |
1 |
0.0000 |
| 176 |
RASH MACULAR |
1 |
0.0000 |
| 177 |
HYPERKALAEMIA |
1 |
0.0000 |
| 178 |
HYPOXIA |
1 |
0.0000 |
| 179 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 180 |
MOBILITY DECREASED |
2 |
0.0000 |
| 181 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 182 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 183 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 184 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 185 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 186 |
DIABETES MELLITUS |
2 |
0.0000 |
| 187 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 188 |
OEDEMA PERIPHERAL |
3 |
0.0000 |
| 189 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 190 |
HYPERTENSION |
5 |
0.0000 |
| 191 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 192 |
SEPTIC SHOCK |
1 |
0.0000 |
| 193 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 194 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 195 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 196 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 197 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 198 |
CARDIAC DISORDER |
2 |
0.0000 |
| 199 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 200 |
RENAL CANCER |
1 |
0.0000 |
| 201 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 202 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 203 |
LEUKOPENIA |
1 |
0.0000 |
| 204 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 205 |
PARAESTHESIA |
3 |
0.0000 |
| 206 |
MEDICATION ERROR |
1 |
0.0000 |
| 207 |
BONE PAIN |
1 |
0.0000 |
| 208 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 209 |
RHINORRHOEA |
1 |
0.0000 |
| 210 |
FATIGUE |
12 |
0.0000 |
| 211 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 212 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 213 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 214 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 215 |
CONSTIPATION |
3 |
0.0000 |
| 216 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 217 |
ARTHRITIS |
1 |
0.0000 |
| 218 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 219 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 220 |
BALANCE DISORDER |
1 |
0.0000 |
| 221 |
RASH |
5 |
0.0000 |
| 222 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 223 |
TACHYCARDIA |
1 |
0.0000 |
| 224 |
ADVERSE EVENT |
1 |
0.0000 |
| 225 |
DIARRHOEA |
7 |
0.0000 |
| 226 |
CHEST PAIN |
2 |
0.0000 |
| 227 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 228 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 229 |
ASTHENIA |
4 |
0.0000 |
| 230 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 231 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 232 |
SINUSITIS |
1 |
0.0000 |
| 233 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 234 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 235 |
DEATH |
8 |
0.0000 |
| 236 |
PNEUMONIA |
3 |
0.0000 |
| 237 |
SEPSIS |
1 |
0.0000 |
| 238 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 239 |
ASTHMA |
1 |
0.0000 |
| 240 |
SEIZURE |
1 |
0.0000 |
| 241 |
PSORIASIS |
1 |
0.0000 |
| 242 |
RENAL FAILURE |
1 |
0.0000 |
| 243 |
DEHYDRATION |
1 |
0.0000 |
| 244 |
NEUTROPENIA |
1 |
0.0000 |
| 245 |
VISION BLURRED |
1 |
0.0000 |
| 246 |
COUGH |
2 |
0.0000 |
| 247 |
HYPOAESTHESIA |
1 |
0.0000 |
| 248 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 249 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 250 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 251 |
PYREXIA |
2 |
0.0000 |
| 252 |
COVID-19 |
1 |
0.0000 |
| 253 |
ANAEMIA |
1 |
0.0000 |
| 254 |
HYPOTENSION |
1 |
0.0000 |
| 255 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 256 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 257 |
ARTHRALGIA |
2 |
0.0000 |
| 258 |
OFF LABEL USE |
4 |
0.0000 |
| 259 |
MALAISE |
2 |
0.0000 |
| 260 |
VOMITING |
2 |
0.0000 |
| 261 |
DRUG INEFFECTIVE |
5 |
0.0000 |
| 262 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 263 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 264 |
HEADACHE |
2 |
0.0000 |
| 265 |
PRURITUS |
1 |
0.0000 |
| 266 |
NAUSEA |
2 |
0.0000 |